XML 32 R23.htm IDEA: XBRL DOCUMENT v3.25.3
Schedule of Segment Information Related to Statement of Operations (Details) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting [Abstract]        
Revenue $ 359,444 $ 354,408 $ 1,049,125 $ 1,157,380
Operating Expenses:        
Employee compensation 235,785 230,896 834,855 746,582
Professional fees 52,382 37,500 185,039 151,614
Directors fees and expenses 148 227,254 121,306
Marketing and investor relations 109,201 27,946 187,467 125,187
Insurance [1] 39,535 46,151 131,079 144,534
Occupancy costs 21,097 13,306 63,229 43,457
Credit loss expense 25,001 124,253 25,001
Patent costs 31,826 20,339 58,944 54,535
Stock listing fees 17,500 16,375 52,500 49,125
Legal fees 5,087 1,070 33,062
Depreciation and amortization 2,879 3,789 8,603 11,211
Other operating expenses [2] 11,289 28,476 59,748 59,538
Operating expenses 521,642 454,866 1,934,041 1,565,152
Research and Development Expenses        
Employee compensation 35,100 35,511 125,743 115,561
Insurance [1] 38,668 45,174 128,302 140,973
Occupancy costs 64,578 43,437 192,374 133,883
Depreciation and amortization 233 2,841 676 8,371
Other research and development costs 3,167 4,283 26,614 11,029
Research and development expenses 141,746 131,246 473,709 409,817
Operating loss $ (303,944) $ (231,704) $ (1,358,625) $ (817,589)
[1] Insurance includes all coverage including property, liability, directors’ and officers’ and employees’ medical.
[2] Other operating expenses and other research and development expenses consist principally of miscellaneous expenses, each of which is under the Company’s threshold to be separately presented as a significant expense.